These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14254831)

  • 41. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 42. [TECHNIC FOR THE PREPARATION OF A FIBRINOGEN REAGENT FOR DETERMINATIONS OF FIBRINOLYTIC ACTIVITY].
    BLATRIX C; VIGNAL A; STEINBUCH M
    Hemostase; 1963; 3():179-86. PubMed ID: 14050814
    [No Abstract]   [Full Text] [Related]  

  • 43. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 44. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281
    [No Abstract]   [Full Text] [Related]  

  • 45. [STREPTOKINASE INACTIVATION WITH POLYAMINOSTYROL].
    CAVIEZEL O
    Schweiz Med Wochenschr; 1964 Aug; 94():1194-8. PubMed ID: 14257919
    [No Abstract]   [Full Text] [Related]  

  • 46. [A contribution to fibrinolytic therapy with streptokinase and streptolysin].
    FISCHBACHER W
    Thromb Diath Haemorrh; 1961 Dec; 6():547-72. PubMed ID: 13893097
    [No Abstract]   [Full Text] [Related]  

  • 47. [PRESENT STATUS OF THROMBOLYTIC THERAPY].
    VAIREL EG; ANTOINE G
    Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832
    [No Abstract]   [Full Text] [Related]  

  • 48. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 49. [SALIVA AND BLOOD COAGULATION].
    SCHULTE W
    Dtsch Zahnarztl Z; 1964 Mar; 19():193-201. PubMed ID: 14140027
    [No Abstract]   [Full Text] [Related]  

  • 50. [MEASURE OF PLASMA RESISTANCE TO LYSIS BY STREPTOKINASE. APPLICATION TO PATHOLOGIC THROMBOSIS. NEW TECHNIQUE FOR THE MEASUREMENT OF ACTIVATION OF PLASMINOGEN INHIBITORS].
    VAIREL EG; THELY MH
    Sangre (Barc); 1964; 41():447-50. PubMed ID: 14248833
    [No Abstract]   [Full Text] [Related]  

  • 51. PLASMA CHANGES DURING FIBRINOLYTIC THERAPY.
    JOHNSON JF; BARNHART MI; GILROY J; MEYER JS
    Vox Sang; 1963; 8():484-8. PubMed ID: 14059845
    [No Abstract]   [Full Text] [Related]  

  • 52. THE FIBRINOLYTIC SYSTEM IN BLOOD AFTER RETENTION OF A DEAD FETUS AND DURING NORMAL LABOR.
    BRAKMAN P; KING AE
    Am J Obstet Gynecol; 1965 May; 92():221-6. PubMed ID: 14281832
    [No Abstract]   [Full Text] [Related]  

  • 53. FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG.
    WOROWSKI K; NIEWIAROWSKI S; PROKOPOWICZ J
    Thromb Diath Haemorrh; 1964 Oct; 12():87-104. PubMed ID: 14224648
    [No Abstract]   [Full Text] [Related]  

  • 54. THE INHIBITORY EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE AS RELATED TO PROTEOLYTIC ACTIVITY AND PROACTIVATOR FUNCTION OF HUMAN EUGLOBULIN.
    HELLE I
    Scand J Haematol; 1964; 1():240-56. PubMed ID: 14214904
    [No Abstract]   [Full Text] [Related]  

  • 55. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
    VERSTRAETE M; VERMYLEN J; VERMYLEN C; DEVREKER RA
    Thromb Diath Haemorrh; 1964 Dec; 12():391-5. PubMed ID: 14254698
    [No Abstract]   [Full Text] [Related]  

  • 56. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [THROMBOLYSIS CAUSED BY PLASMINOGEN ACTIVATION AND BY DIRECT PROTEOLYSIS].
    SCHMIDT HW
    Arzneimittelforschung; 1965 Feb; 15():132-5. PubMed ID: 14263132
    [No Abstract]   [Full Text] [Related]  

  • 58. [Methodological research on the control of fibrinolytic therapy with streptokinase].
    CROLLE G; MARX R
    Rass Fisiopatol Clin Ter; 1962; 34():17-45. PubMed ID: 13882309
    [No Abstract]   [Full Text] [Related]  

  • 59. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.
    MCNICOL GP; DOUGLAS AS
    Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.